Answers are grounded in this paper and cite their sources.
Sir:Anincreasing number of patients with marked immunosuppression as a result of transplantation, cancer and infection with Hiy has led to the increased, and widespread use of systemic antifungal agents.1}Currently available treatment is limited to 5-fluorocytosine, amphotericin Band azoles such as fluconazole and itraconazole.However, various problems effect the use of these agents.Among the major concerns are toxicity, rapid development of resistance, fungistatic effect and narrow antifungal spectrum, depending on the agent.In the search for new antifungals, fungal cell wall synthesis is an attractive target due to the presence of a number of fungi-specific enzymes,2) leading to the expectation of selective toxicity to the parasite and not to the host.Inhibitors of l,3-/3-glucan synthase, a key component of the cell wall of most pathogenic fungi, in particular of the pp.674 -676
No takes yet. Share an insight, caveat, or question.
Tomishima et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: